EFFECT OF 11C-METHIONINE-POSITRON EMISSION TOMOGRAPHY ON GROSS TUMOR VOLUME DELINEATION IN STEREOTACTIC RADIOTHERAPY OF SKULL BASE MENINGIOMAS

被引:64
|
作者
Astner, Sabrina T. [1 ]
Dobrei-Ciuchendea, Mihaela [1 ]
Essler, Markus [2 ]
Bundschuh, Ralf A. [2 ]
Sai, Heitetsu [1 ]
Schwaiger, Markus [2 ]
Molls, Michael [1 ]
Weber, Wolfgang A. [3 ]
Grosu, Anca-Ligia [4 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-81675 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany
[3] Univ Freiburg, Dept Radiat Oncol, Freiburg, Germany
[4] Univ Freiburg, Dept Nucl Med, Freiburg, Germany
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 04期
关键词
Meningioma; Positron emission tomography; C-11-methionine; Gross tumor volume; High-precision radiotherapy;
D O I
10.1016/j.ijrobp.2008.02.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the effect of trimodal image fusion using computed tomography (CT), magnetic resonance imaging (MRI) and C-11-methionine positron emission tomography (MET-PET) for gross tumor volume delineation in fractionated stereotactic radiotherapy of skull base meningiomas. Patients and Methods: In 32 patients with skull base meningiomas, the gross tumor volume (GTV) was outlined on CT scans fused to contrast-enhanced MRI (GTV-MRI/CT). A second GTV, encompassing the MET-PET positive region only (GTV-PET), was generated. The additional information obtained by MET-PET concerning the GTV delineation was evaluated using the PET/CT/MRI co-registered images. The sizes of the overlapping regions of GTV-MRI/CT and GTV-PET were calculated and the amounts of additional volumes added by the complementing modality determined. Results: The addition of MET-PET was beneficial for GTV delineation in all but 3 patients. MET-PET detected small tumor portions with a mean volume of 1.6 +/- 1.7 cm(3) that were not identified by CT or MRI. The mean percentage of enlargement of the GTV using MET-PET as an additional imaging method was 9.4 % +/- 10.7 %. Conclusions: Our data have demonstrated that integration of MET-PET in radiotherapy planning of skull base meningiomas can influence the GTV, possibly resulting in an increase, as well as in a decrease. (c) 2008 Elsevier Inc.
引用
收藏
页码:1161 / 1167
页数:7
相关论文
共 50 条
  • [21] Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography
    Nuutinen, J
    Jyrkkiö, S
    Lehikoinen, P
    Lindholm, P
    Minn, H
    RADIOTHERAPY AND ONCOLOGY, 1999, 52 (03) : 225 - 232
  • [22] EVALUATION OF RESPONSE TO RADIOTHERAPY IN DEAD-END NECK-CANCER BY POSITRON EMISSION TOMOGRAPHY AND [C-11] METHIONINE
    LINDHOLM, P
    LESKINENKALLIO, S
    GRENMAN, R
    LEHIKOINEN, P
    NAGREN, K
    TERAS, M
    RUOTSALAINEN, U
    JOENSUU, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (03): : 787 - 794
  • [23] Short diameter may be a useful simple indicator of the tumor response in skull base meningiomas after conventionally fractionated stereotactic radiotherapy
    Takehana, Keiichi
    Nakamura, Daisuke
    Abdelghaffar, Alshaymaa
    Uto, Megumi
    Katagiri, Tomohiro
    Arakawa, Yoshiki
    Mineharu, Yohei
    Miyamoto, Susumu
    Mizowaki, Takashi
    EUROPEAN RADIOLOGY, 2021, 31 (08) : 6367 - 6373
  • [24] Short diameter may be a useful simple indicator of the tumor response in skull base meningiomas after conventionally fractionated stereotactic radiotherapy
    Keiichi Takehana
    Daisuke Nakamura
    Alshaymaa Abdelghaffar
    Megumi Uto
    Tomohiro Katagiri
    Yoshiki Arakawa
    Yohei Mineharu
    Susumu Miyamoto
    Takashi Mizowaki
    European Radiology, 2021, 31 : 6367 - 6373
  • [25] [11C]methionine positron emission tomography for the evaluation of pancreatic exocrine function in chronic pancreatitis
    Takasu, A
    Shimosegawa, T
    Shimosegawa, E
    Hatazawa, J
    Nagasaki, Y
    Kimura, K
    Fujita, M
    Toyota, T
    PANCREAS, 2001, 22 (02) : 203 - 209
  • [26] Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly
    Haberbosch, Linus
    MacFarlane, James
    Koulouri, Olympia
    Gillett, Daniel
    Powlson, Andrew S.
    Oddy, Sue
    Halsall, David J.
    Huynh, Kevin A.
    Jones, Jonathan
    Cheow, Heok K.
    Spranger, Joachim
    Mai, Knut
    Strasburger, Christian J.
    Mannion, Richard J.
    Gurnell, Mark
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2024, 190 (04) : 307 - 313
  • [27] Role of [11C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours
    Cicuendez, Marta
    Lorenzo-Bosquet, Caries
    Cuberas-Borros, Gemma
    Martinez-Ricarte, Francisco
    Cordero, Esteban
    Martinez-Saez, Elena
    Castell-Conesa, Joan
    Sahuquillo, Juan
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2015, 139 : 328 - 333
  • [28] Positron emission tomography 11C-methionine and survival in patients with low-grade gliomas
    Ribom, D
    Eriksson, A
    Hartman, M
    Engler, H
    Nilsson, A
    Långström, B
    Bolander, H
    Bergström, M
    Smits, A
    CANCER, 2001, 92 (06) : 1541 - 1549
  • [29] Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies
    Pirotte, B
    Goldman, S
    Massager, N
    David, P
    Wikler, D
    Lipszyc, M
    Salmon, I
    Brotchi, J
    Levivier, M
    JOURNAL OF NEUROSURGERY, 2004, 101 (03) : 476 - 483
  • [30] Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi, N
    Sunada, I
    Iwai, Y
    Yamanaka, K
    Tanaka, K
    Takami, T
    Otsuka, Y
    Sakamoto, S
    Ohata, K
    Goto, T
    Hara, M
    JOURNAL OF NEUROSURGERY, 2003, 98 (05) : 1056 - 1064